Abstract
Recent advancements and progress in proteomics technologies and research protocols have made a demonstrable impact upon clinical investigations, particularly in the area of cancer research. This chapter reviews the overall requirements and approaches involved in clinical proteomics research with particular emphasis on and review of accomplishments in the field of cancer research and therapy. A detailed discussion of the challenges in clinical proteomic research is presented along with a valuable review of protein purification and protein analytical platforms. Extensive discussion on the use of various clinical proteomic mass spectrometric approaches is provided.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adkins, J. N. et al. 2002. Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry. Mol Cell Proteomics 1:947–955.
Aebersold, R. et al. 2000. New approaches to quantitative proteome analysis. Biotecnol Apl 17:46–47.
Alessandro, R. et al. 2005. Proteomic approaches in colon cancer: promising tools for new cancer markers and drug target discovery. Clin Colorectal Cancer 4:396–402.
Alfonso, P. et al. 2005. Proteomic expression analysis of colorectal cancer by two-dimensional differential gel electrophoresis. Proteomics 5:2602–2611.
Appel, R. et al. 1988. Automatic classification of two-dimensional gel electrophoresis pictures by heuristic clustering analysis: a step toward machine learning. Electrophoresis 9:136–142.
Appel, R. D. et al. 1991. The MELANIE project: from a biopsy to automatic protein map interpretation by computer. Electrophoresis 12:722–735.
Arnott, D. P. et al. 1996. Identification of proteins from two-dimensional electrophoresis gels by peptide mass fingerprinting. ACS Symp Ser 619:226–243.
Beer, I. et al. 2004. Improving large-scale proteomics by clustering of mass spectrometry data. Proteomics 4:950–960.
Benzinger, A. et al. 2005. Targeted proteomic analysis of 14-3-3s, a p53 effector commonly silenced in cancer. Mol Cell Proteomics 4:785–795.
Bergen, H. R. III et al. 2003. Discovery of ovarian cancer biomarkers in serum using NanoLC electrospray ionization TOF and FT-ICR mass spectrometry. Dis Markers 19:239–249.
Bern, M. et al. 2004. Automatic quality assessment of Peptide tandem mass spectra. Bioinformatics 20(Suppl 1):I49–I54.
Bienvenut, W. V. et al. 2002. Matrix-assisted laser desorption/ionization-tandem mass spectrometry with high resolution and sensitivity for identification and characterization of proteins. Proteomics 2:868–876.
Borisov, O. V. et al. 2002. Low-energy collision-induced dissociation fragmentation analysis of cysteinyl-modified peptides. Anal Chem 74:2284–2292.
Boschetti, E. 1994. Advanced sorbents for preparative protein separation purposes. J Chromatogr 658:207.
Brill, L. M. et al. 2004. Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry. Anal Chem 76:2763.
Brzeski, H. et al. 2003. Albumin depletion method for improved plasma glycoprotein analysis by two-dimensional difference gel electrophoresis. Biotechniques 35:1128.
Cargile, B. J. et al. 2004. Potential for false positive identifications from large databases through tandem mass spectrometry. J Proteome Res 3:1082–1085.
Castagna, A. et al. 2005. Exploring the hidden human urinary proteome via ligand library beads. J Proteome Res 4:1917–1930.
Chamrad, D. C. et al. 2004. Evaluation of algorithms for protein identification from sequence databases using mass spectrometry data. Proteomics 4:619–628.
Chen, E. I. et al. 2005. Maspin alters the carcinoma proteome. FASEB J 19:1123–1124, 10 1096/fj 04-2970fje.
Chong, B. E. et al. 2001. Differential screening and mass mapping of proteins from premalignant and cancer cell lines using nonporous reversed-phase HPLC coupled with mass spectrometric analysis. Anal Chem 73:1219–1227.
Chong, P. K. et al. 2006. Isobaric tags for relative and absolute quantitation (iTRAQ) reproducibility: Implication of multiple injections. J Proteome Res 5:1232–1240.
Clarke, W., and Chan, D. W. 2005. ProteinChips: the essential tools for proteomic biomarker discovery and future clinical diagnostics. Clin Chem Lab Med 43:1279–1280.
Corthals, G. L. et al. 2000b. The dynamic range of protein expression: a challenge for proteomic research. Electrophoresis 21:1104.
Davis, M. T. et al. 2001a. Automated LC-LC-MS-MS platform using binary ion-exchange and gradient reversed-phase chromatography for improved proteomic analyses. J Chromatogr B: Biomed Sci Appl 752:281–291.
Davis, M. T. et al. 2001b. Towards defining the urinary proteome using liquid chromatography-tandem mass spectrometry. II. Limitations of complex mixture analyses. Proteomics 1:108–117.
Demirev, P. A. et al. 2001. Tandem mass spectrometry of intact proteins for characterization of biomarkers from Bacillus cereus T spores. Anal Chem 73:5725–5731.
DeSouza, L. et al. 2005. Search for cancer markers from endometrial tissues using differentially labeled tags iTRAQ and cICAT with multidimensional liquid chromatography and tandem mass spectrometry. J Proteome Res 4:377–386.
Ding, L. et al. 1999. High-efficiency MALDI-QIT-ToF mass spectrometer. Proc SPIE-Int Soc Opt Eng 3777:144–155.
Durr, E. et al. 2004. Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture. Nat Biotechnol 22:985–992.
Fernandez, M. A. et al. 1996. Characterization of protein adsorption by composite silica-polyacrylamide gel anion exchangers II. Mass transfer in packed columns and predictability of breakthrough behavior. J Chromatogr 746:185–198.
Ficarro, S. B. et al. 2002. Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cervisiae. Nat Biotechnol 20:301–305.
Figeys, D. et al. 2001. Mass spectrometry for the study of protein–protein interactions. Methods 24:230.
Fountoulakis, M., and Juranville, J. F. 2003. Enrichment of low-abundance brain proteins by preparative electrophoresis. Anal Biochem 313:267.
Fountoulakis, M. et al. 1999. Enrichment of low-copy-number gene products by hydrophobic interaction chromatography. J Chromatogr A 833:157–168.
Friedman, D. B. et al. 2004. Proteome analysis of human colon cancer by two-dimensional difference gel electrophoresis and mass spectrometry. Proteomics 4:793–811.
Fung, E. T. et al. 2001. Protein biochips for differential profiling. Curr Opin Biotechnol 12:65–69.
Fung, E. T. et al. 2005. Classification of cancer types by measuring variants of host response proteins using SELDI serum assays. Int J Cancer 115:783–789.
Ge, Y. et al. 2002. Top down characterization of larger proteins (45 kDa) by electron capture dissociation mass spectrometry. J Am Chem Soc 124:672–678.
Geho, D. H. et al. 2004. Opportunities for nanotechnology-based innovation in tissue proteomics. Biomed Microdevices 6:231–239.
Geng, M. et al. 2001. Proteomics of glycoproteins based on affinity selection of glycopeptides from tryptic digests. J Chromatogr 752:293.
Ghosh, D. et al. 2004. Lectin affinity as an approach to the proteomic analysis of membrane glycoproteins. J Proteome Res 3:841.
Goerg, A. et al. 2004. Current two-dimensional electrophoresis technology for proteomics. Proteomics 4:3665–3685.
Gorg, A. et al. 2002. Sample prefractionation with Sephadex isoelectric focusing prior to narrow pH range two-dimensional gels. Proteomics 2:1652–1657.
Gronborg, M. et al. 2002. A mass spectrometry-based proteomic approach for identification of serine/threonine-phosphorylated proteins by enrichment with phospho-specific antibodies: identification of a novel protein, Frigg, as a protein kinase A substrate. Mol Cell Proteomics 1:517–527.
Gygi, S. P. et al. 1999. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 17:994–999.
Gygi et al. 2000. Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Proc Natl Acad Sci USA 17:9390–9395
Henzel, W. J. et al. 1993. Identifying proteins from two-dimensional gels by molecular mass searching of peptide fragments in protein sequence databases. Proc Nat Acad Sci USA 90:5011–5015
Higdon, R. et al. 2004. LIP index for peptide classification using MS/MS and SEQUEST search via logistic regression. OMICS 8:357–369.
Hoffman, P. et al. 2001. Continuous free-flow electrophoresis separation of cytosolic proteins from the human colon carcinoma cell line LIM 1215: a non two-dimensional gel electrophoresis-based proteome analysis strategy. Proteomics 1:807–818.
Horn, D. M. et al. 2000a. Automated de novo sequencing of proteins by tandem high-resolution mass spectrometry. Proc Nat Acad Sci USA 97:10313–10317.
Horn, D. M. et al. 2000b. Automated reduction and interpretation of high resolution electrospray mass spectra of large molecules. J Am Soc Mass Spectrom 11:320–332.
Jain, K. K. 2002. Role of Proteomics in diagnosis of Cancer. Technol Cancer Res Treat 4: 281–286.
Jessani, N. et al. 2005. A streamlined platform for high-content functional proteomics of primary human specimens. Nat Methods 2:691–697.
Juhasz, P. et al. 2002. MALDI-TOF/TOF technology for peptide sequencing and protein identification. Mass Spectrom Hyphenated Techn Neuropeptide Res 375–413.
Kachman, M. T. et al. 2002. A 2-D liquid separations/mass mapping method for interlysate comparison of ovarian cancers. Anal Chem 74:1779–1791.
Kaiser, R. E. Jr. et al. 1990. Collisionally activated dissociation of peptides using a quadrupole ion-trap mass spectrometer. Rapid Commun Mass Spectrom 4:30–33.
Kaufman, R. et al. 1993. Mass spectrometric sequencing of linear peptides by product-ion analysis in a felfectron time-of-flight mass spectrometer using matrix-assisted laser desorption ionization. Rapid Commun Mass Spectrom 7:902–910.
Kelleher, N. L. et al. 1999. Top down versus bottom up protein characterization by tandem high-resolution mass spectrometry. J Am Chem Soc 121:806–812.
Kislinger, T., and Emili, A. 2005. Multidimensional protein identification technology: current status and future prospects. Expert Rev Proteomics 2:27–39.
Kobayashi, H. et al. 2003. Free-flow electrophoresis in a microfabricated chamber with a micromodule fraction separator continuous separation of proteins. J Chromatogr A 990:169–178.
Krutchinksy, A. N. et al. 1998. Orthogonal injection of matrix-assisted laser desorption/ionization ions into a time-of-flight spectrometer through a collisional damping interface. Rapid Commun Mass Spectrom 12:508–518.
Lin, S. et al. 2003. Means of hydrolyzing proteins isolated upon ProteinChip array surfaces: Chemical and enzymatic approaches. P. Michael Conn (ed.). Handbook of Proteomic Methods. Totowa, NJ: Humana, pp. 59–72.
Link, A. J. et al. 1997. A strategy for the identification of proteins localized to subcellular spaces: applications to E. coli periplasmic proteins. Int J Mass Spectrom Ion Proc 160:303–316.
Loo, R. R. O. et al. 1996. Interfacing polyacrylamide gel electrophoresis with mass spectrometry. Techniques in Protein Chemistry VII Symposium of the Protein Society, 9th, Boston, July 8–12, 1995, 305–313.
Loo, R. R. O. et al. 2001. Virtual 2-D gel electrophoresis: visualization and analysis of the E. coli proteome by mass spectrometry. Anal Chem 73:4063–4070.
Lopez, M. F. 2000. Better approaches to finding the needle in a haystack: optimizing proteome analysis through automation. Electrophoresis 21:1082–1093.
Lopez, M. F. et al. 2000. High-throughput profiling of the mitochondrial proteome using affinity fractionation and automation. Electrophoresis 21:3427–3440.
MacCoss, M. J. et al. 2003. A correlation algorithm for the automated quantitative analysis of shotgun proteomics data. Anal Chem 75:6912–6921.
Mann, M. et al. 1993. Use of mass spectrometric molecular weight information to identify proteins in sequence databases. Biol Mass Spectrom 22:338–345.
Martosella, J. et al. 2005. Reversed-phase high-performance liquid chromatographic prefractionation of immunodepleted human serum proteins to enhance mass spectrometry identification of lower abundant proteins. J Proteome Res 4:1522–1537.
Mauri, P. et al. 2005. Identification of proteins released by pancreatic cancer cells by multidimensional protein identification technology: a strategy for identification of novel cancer markers. FASEB J 19:1125–1127, doi:10.1096/fj 04–3000fje.
McLafferty, F. W. 2001. Tandem mass spectrometric analysis of complex biological mixtures. Int J Mass Spectrom 212:81–87.
McLuckey, S. A. et al. 1991. Ion spray liquid chromatography/ion trap mass spectrometry determination of biomolecules. Anal Chem 63:375–383.
Meehan, K. L., and Sadar, M. D. 2004. Quantitative profiling of LNCaP prostate cancer cells using isotope-coded affinity tags and mass spectrometry. Proteomics 4:1116–1134.
Mehta, A. I. et al. 2003. Biomarker amplification by serum carrier protein binding. Disease Markers 19:1–10.
Melander, W. R. et al. 1984. Salt-mediated retention of proteins in hydrophobic-interaction chromatography. Application of solvophobic theory. J Chromatogr 317:67–85.
Meng, F. et al. 2004. Molecular-level description of proteins from saccharomyces cerevisiae using Q-FT mass spectrometry for top down proteomics. Anal Chem 76:2852–2858.
Merchant, M., and Weinberger, S. R. 2000. Recent advancements in surface-enhanced laser desoprtion/ionization time-of-flight mass spectrometry. Electrophoresis 21:1164–1177.
Michel, P. et al. 2003. Protein fractionation in a multicompartment device using Off-Gel isoelectric focusing. Electrophoresis 24:3–11.
Opiteck, G. J. et al. 1998. Comprehensive two-dimensional higher-performance liquid chromatography for the isolation of overexpressed proteins and proteome mapping. Anal Biochem 258:349–361.
Overall, C. M., and Dean, R. A. 2006. Degradomics: Systems biology of the protease web. Pleiotropic roles of MMPs in cancer. Cancer Metastasis Rev 25:69–75.
Paoletti, A. C. et al. 2004. Principles and applications of multidimensional protein identification technology. Exp Review of Proteomics 1:275–282.
Park, O. K. 2004. Proteomic studies in plants. J Biochem Mol Biol 37:133–138.
Pawlik, T. M. et al. 2006. Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein. BMC Cancer 6:68.
Pun, T. et al. 1988. Computerized classification of two-dimensional gel electrophoretograms by correspondence analysis and ascendant hierarchical clustering. Appl Theor Electrophor 1:3–9.
Qin, J., and Chait, B. T. 1995. Preferential fragmentation of protonated gas-phase peptide ions adjacent to acidic amino acid residues. J Am Chem Soc 117:5411–5412.
Ramamoorthy, S. et al. 2004. Intracellular mechanisms mediating the anti-apoptotic action of gastrin. Biochem Biophys Res Commun 323:44–48.
Razumovskaya, J. et al. 2004. A computational method for assessing peptide- identification reliability in tandem mass spectrometry analysis with SEQUEST. Proteomics 4:961–969.
Reid, G. E., and McLuckey, S. A. 2002.\“Top down\” protein characterization via tandem mass spectrometry. J Mass Spectrom 37:663–675.
Ren, L. et al. 2003. Improved immunomatrix methods to detect protein:protein interactions. J Biochem Biophys Methods 57:143–157.
Righetti, P. G. et al. 1990. Preparative purification of human monoclonal antibody isoforms in a multi-compartment electrolyser with immobiline membranes. J Chromatogr 500:681–696.
Righetti, P. G. et al. 2005. Proteome analysis in the clinical chemistry laboratory: Myth or reality? Clinica Chimica Acta 357:123–139.
Ros, A. et al. 2002. Protein purification by off-gel electrophoresis. Proteomics 2:151–156.
Schulze, W. X., and Mann, M. 2004. Novel proteomic screen for peptide-protein interactions. J Biol Chem 279:10756–10764.
Senko, M. W. et al. 1995. Automated assignment of charge states from resolved isotopic peaks for multiply charged ions. J Am Soc Mass Spectrom 6:52–56.
Shadforth, I. P. et al. 2005. i-Tracker: for quantitative proteomics using iTRAQ. BMC Genomics 6:145.
Shang, T. Q. et al. 2003. Carrier ampholyte-free solution isoelectric focusing as a prefractionation method for the proteomic analysis of complex protein mixtures. Electrophoresis 24:2359–2368.
Shevchenko, A. et al. 1997. Rapid ‘de Novo’ peptide sequencing by a combination of nanoelectrospray isotopic labeling and a quadrupole/time-of-flight mass spectrometer. Rapid Commun Mass Spectrom 11:1015–1024.
Smith, S. D. et al. 2004. Using immobilized metal affinity chromatography, two-dimensional electrophoresis and mass spectrometry to identify hepatocellular proteins with copper-binding ability. J Proteome Res 3:834–840.
Somiari, R. I. et al. 2005. Proteomics of breast carcinoma. J Chromatogr B Anal Technol Biomed Life Sci 815:215–225.
Staby, A., and Mollerup, J. 1996. Solute retention of lysozyme in hydrophobic interaction perfusion chromatography. J Chromatogr A 734:205–212.
Tao, W. A., and Aebersold, R. 2003. Advances in quantitative proteomics via stable isotope tagging and mass spectrometry. Curr Opin Biotechnol 14:110–118.
Thadikkaran, L. et al. 2005. Recent advances in blood-related proteomics. Proteomics 5:3019–3034.
Thulasiraman, V. et al. 2005. Reduction of the concentration difference of proteins in biological liquids using a library of combinatorial ligands. Electrophoresis 26:3561–3571.
Tirumalai, R. S. et al. 2003. Characterization of the low molecular weight human serum proteome. Mol Cell Proteomics 2:1096–1103.
Tissot, J. D. et al. 1991. High-resolution two-dimensional protein electrophoresis of pathological plasma/serum. Appl Theor Electrophoresis 2:7–12.
Tomlinson, A. J., and Chicz, R. M. 2003. Microcapillary liquid chromatography/tandem mass spectrometry using alkaline pH mobile phases and positive ion detection. Rapid Commun Mass Spectrom 17:909–916.
Unlu, M. et al. 1997. Difference gel electrophoresis. A single gel method for detecting changes in protein extracts. Electrophoresis 18:2071–2077.
Van Berkel, G. J. et al. 1990. Electrospray ionization combined with ion trap mass spectrometry. Anal Chem 62:1284–1295.
Wagner, K. et al. 2002. An automated on-line multidimensional HPLC system for protein and peptide mapping with integrated sample preparation. Anal Chem 74:809–820.
Walker, A. K. et al. 2001. Mass spectrometric imaging of immobilized pH gradient gels and creation of\“virtual\” two-dimensional gels. Electrophoresis 22:933–945.
Wall, D. B. et al. 2000. Isoelectric focusing nonporous RP HPLC: a two-dimensional liquid-phase separation method for mapping of cellular proteins with identification using MALDI-TOF mass spectrometry. Anal Chem 72:1099–1111.
Wall, D. B. et al. 2001. Isoelectric focusing nonporous silica reversed-phase high-performance liquid chromatography/electrospray ionization time-of-flight mass spectrometry: a three-dimensional liquid-phase protein separation method as applied to the human erythroleukemia cell-line. Rapid Commun Mass Spectrom 15:1649–1661.
Washburn, M. P. 2004. Technique review: Utilisation of proteomics datasets generated via multidimensional protein identification technology (MudPIT). Brief Funct Genomic Proteomic 3:280–286.
Washburn, M. P. et al. 2001. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 19:242–247.
Wasinger, V. C. et al. 1995. Progress with gene-product mapping of the Mollicutes: Mycoplasma genitalium. Electrophoresis 16:1090–1094.
Watts, A. D. et al. 1997. Separation of tumor necrosis factor alpha isoforms by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis 18:1806–1091.
Weinberger, S. R. et al. 2002. Current achievements using ProteinChip array technology. Curr Opin Chem Biol 6:86–91.
Wenger, P. et al. 1987. Amphoteric, isoelectric immobiline membranes for preparative isoelectric focusing. J Biochem Biophys Methods 14:29–43.
Wilkins, M. R. et al. 1996a. From proteins to proteomes: large scale protein identification by two-dimensional electrophoresis and amino acid analysis. Bio/technology 14:61–65.
Wilkins, M. R. et al. 1996b. Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it. Biotechnol Genetic Eng Rev 13:19–50.
Wilkins, M. R. et al. 1996c. Current challenges and future applications for protein maps and post-translational vector maps in proteome projects. Electrophoresis 17:830–838.
Williams, K. L. et al. 1996. Analytical biotechnology and proteome analysis. Australasian Biotechnol 6:162–164, 166–167.
Wilson, L. L. et al. 2004. Detection of differentially expressed proteins in early-stage melanoma patients using SELDI-TOF mass spectrometry. Ann N Y Acad Sci 1022:317–322.
Wolters, D. A. 2004. Applications of MudPIT technology. BIOspektrum 10:162–164.
Wolters, D. A. et al. 2001. An automated multidimensional protein identification technology for shotgun proteomics. Anal Chem 73:5683–5690.
Wright, M. E., and Aebersold, R. 2003. Differential expression proteomic analysis using isotope coded affinity tags. Proteomic Genomic Anal Cardiovasc Dis 213–233.
Wright, M. E. et al. 2004. Identification of androgen-coregulated protein networks from the microsomes of human prostate cancer cells. Genome Biol 5(1):R4.
Wu, Q. et al. 1995. Characterization of cytochrome c variants with high-resolution FTICR mass spectrometry: Correlation of fragmentation and structure. Anal Chem 67:2498–2509.
Wu, W. W. et al. 2006. Comparative study of three proteomic quantitative methods, DIGE, cICAT, and iTRAQ, using 2D gel- or LC-MALDI TOF/TOF. J Proteome Res 5:651–658.
Yan, B. et al. 2005. A graph-theoretic approach for the separation of b and y ions in tandem mass spectra. Bioinformatics 21:563–574.
Yates, J. R. III et al. 1995. Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database. Anal Chem 67:1426–1436.
Yergey, A. L. et al. 2002. De novo sequencing of peptides using MALDI/TOF-TOF. J Am Soc Mass Spectrom 13:784–791.
Yu, L. R. et al. 2002. Isotope-coded affinity tag analysis of native and camptothecin-treated cortical neurons. Bioforum Int 6:328–331.
Yuan, X., and Desiderio, D. M. 2003. Proteomics analysis of phosphotyrosyl-proteins in human lumbar cerebrospinal fluid. J Proteome Res 5:476–487.
Zhang, Z. et al. 2004a. Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res 64:5882–5890.
Zhang, Z. et al. 2004b. Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res 64:5882–5890.
Zhou, H. et al. 2004a. Quantitative protein analysis by solid phase isotope tagging and mass spectrometry. Methods Mol Biol 261:511–518.
Zhou, M. et al. 2004b. An investigation into the human serum “interactome”. Electrophoresis 25:1289.
Zhu, Y., and Lubman, D. M. 2004. Narrow-band fractionation of proteins from whole cell lysates using isoelectric membrane focusing and nonporous reversed-phase separations. Electrophoresis 25:949–958.
Zolotarjova, N. et al. 2005. Differences among techniques for high-abundant protein depletion. Proteomics 5:3304–3313.
Zuo, X., and Speicher, D. W. 2002. Comprehensive analysis of complex proteomes using microscale solution isoelectricfocusing prior to narrow pH range two-dimensional electrophoresis. Proteomics 2:58–68.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Weinberger, S., Boschetti, E. (2009). Proteomic Methods in Cancer Research. In: Gordon, G. (eds) Bioinformatics in Cancer and Cancer Therapy. Cancer Drug Discovery and Development. Humana Press. https://doi.org/10.1007/978-1-59745-576-3_6
Download citation
DOI: https://doi.org/10.1007/978-1-59745-576-3_6
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-58829-753-2
Online ISBN: 978-1-59745-576-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)